SANOFI-ADR (SNY)

US80105N1054 - ADR

51.11  +0.49 (+0.97%)

News Image
5 days ago - Swedish Orphan Biovitrum AB

NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A

/PRNewswire/ -- Sobi® today announced the publication of full results from the Phase 3 XTEND-Kids study in The New England Journal of Medicine (NEJM)...

News Image
5 days ago - InvestorPlace

Stable Blue-Chip Stocks to Buy Before Earnings Season

Don't miss out on these stable blue-chip stocks to buy now. Explore their potential for steady returns and long-term portfolio growth.

News Image
12 days ago - Sanofi

Sanofi ships U.S. influenza vaccines for the 2024/25 season

/PRNewswire/ -- Sanofi today started shipping its first influenza (flu) vaccines across the U.S. in preparation for the 2024/25 flu season. Following this...

News Image
13 days ago - InvestorPlace

3 Stocks to Sell Immediately Based on the French Election Results

Discover why Engie S.A., Sanofi, and Carrefour are prime candidates for divestment post-French elections amid potential policy impacts.

News Image
17 days ago - Investor's Business Daily

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.

News Image
18 days ago - InvestorPlace

Upcoming Stock Spinoffs: Should You Pounce or Pass?

Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in.

News Image
19 days ago - InvestorPlace

7 Safe Haven Stocks to Buy Before the Next Market Correction

Discover resilient safe haven stocks to weather economic fluctuations in restaurants, pharmaceuticals, household products, and retail.

News Image
19 days ago - InvestorPlace

Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes

After pulling back following May's "Sanofi surge," don't rule out the potential for further needle-moving news with Novavax stock.

News Image
21 days ago - InvestorPlace

Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.

There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.

News Image
23 days ago - The Motley Fool

Where Will Novavax Be in 1 Year?

We will know a lot more about the vaccine maker's long-term prospects in 12 months.

News Image
25 days ago - InvestorPlace

Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?

Vigil Neuroscience stock is up with heavy trading of VIGL shares this morning on news of a $40 million investment from Sanofi.

News Image
a month ago - Swedish Orphan Biovitrum AB

European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A

/PRNewswire/ -- Sobi® today announced the European Commission has granted Marketing Authorisation for ALTUVOCT™ (efanesoctocog alfa), for the treatment and...

News Image
a month ago - The Motley Fool

Is It Too Late to Buy Novavax Stock?

Shares of the vaccine maker are trading up 230% this year.

News Image
a month ago - Investor's Business Daily

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

The companies are closing in on the finish line for two new COPD treatments.

News Image
a month ago - Investor's Business Daily

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club

Enthusiasm is growing for a looming approval in COPD treatment.

News Image
a month ago - The Motley Fool

A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge

The integration of AI and healthcare is well underway.

News Image
a month ago - The Motley Fool

Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These pharma and biotech players could become long-term winners.

News Image
a month ago - Investor's Business Daily

Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK

If approved, this would be the first combination vaccine based on mRNA technology to hit the market.

News Image
2 months ago - InvestorPlace

Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar

These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.

News Image
2 months ago - InvestorPlace

The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash

Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty.

News Image
2 months ago - I-MAB Biopharma

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

/PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential...

News Image
2 months ago - bluecrux

Bluecrux aide Sanofi à exploiter l'IA pour transformer les chaînes d'approvisionnement de demain

/PRNewswire/ -- Sanofi mise tout sur l'IA et souhaite devenir la première entreprise biopharmaceutique alimentée par l'IA à grande échelle. L'entreprise...

News Image
2 months ago - bluecrux

Bluecrux apoya a Sanofi en el aprovechamiento de la IA para transformar las cadenas de suministro del mañana

/PRNewswire/ -- Sanofi apuesta por la IA y quiere convertirse en la primera empresa biofarmacéutica impulsada por IA a escala. La empresa está utilizando la IA...

News Image
2 months ago - InvestorPlace

3 Dividend Stocks to Buy in June 2024 for Dependable Dividend Growth

Explore three reliable dividend growth stocks for June 2024 to expand your investment profits for the second half of the year.

News Image
2 months ago - InvestorPlace

Growth Stocks to Avoid Like the Plague: 3 Overpriced Picks Primed to Plummet

These are the overpriced growth stocks to sell and buy after these names corrected by 20% to 30% in the coming quarters.